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cis-Urocanic acid, a derivative of histidine, is one of essential components of human skin. We found that 
it can bind nickel(II) ions in a pH-dependent manner, with the dissociation constant in the low millimolar 
range, as revealed by potentiometry, and confirmed by isothermal titration calorimetry and UV-vis 
spectroscopy. The binding occurs within the physiological skin pH range. Considering the fact that cis-
urocanic acid is present in the human skin in concentrations as high as millimolar, this molecule may be a 10 
physiologically important player in nickel trafficking in the human organism. 
Introduction 
Urocanic acid (UCA, 3-(1H-imidazol-4-yl)propenoic acid) is 
present in the uppermost layer of the skin (stratum corneum). It is 
produced by histidine ammonia-lyase (histidase) from histidine as 15 
a trans isomer (trans-UCA, Scheme 1). As urocanate hydratase 
(urocanase), the enzyme which catabolizes trans-UCA, is not 
present in the skin, trans-UCA accumulates in the epidermis to 
0.7% dry weight, which means that in live tissue its concentration 
is millimolar.1 trans-UCA isomerizes to cis-urocanic acid (cis-20 
UCA) upon exposure to ultraviolet radiation (Scheme 1). The 
equilibrium concentration for cis-UCA reaches 60-70% of total 
epidermal UCA.2 Both UCA isomers are removed from the skin 
in sweat and by the desquamation process, however some UCA is 
transported to blood and consequently to urine.3,4 UCA, as a 25 
component of Natural Moisturizing Factor (NMF), is involved in 
the regulation of pH of the skin and skin hydration.5,6 On the 
other hand, cis-UCA has been shown to play a role in 
photoimmunosuppresion7-9 and photocarcinogenesis.10 The 
mechanisms of these actions are yet to be elucidated, however. 30 
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Scheme 1. Structures of trans-UCA and cis-UCA. 
 Allergy to nickel is one of the most common causes of allergic 
contact dermatitis. It is estimated that 10-15% of women in the 
general population is sensitive to nickel.11 The mechanism of this 40 
condition has not yet been fully elucidated. One of the important 
unexplored factors is the first step of delivering Ni(II) to the 
organism. It is possible that a role in it is played by metal 
complexes with biomolecules present in the uppermost layers of 
the skin. 45 
 Considering the similarity of cis-UCA and histidine we 
assumed that this molecule can bind Ni(II), as the ability of 
histidine to form strong Ni(II) complexes is well documented.12,13 
Using UV-vis spectrophotometry, potentiometry and isothermal 
titration calorimetry (ITC) we proved that cis-UCA molecule 50 
interacts with Ni(II) ions. We measured stoichiometry, stability 
constants, enthalpy and entropy of these interactions. Our results 
suggest a possibility of interaction of cis-UCA with Ni(II) in 
human skin. 
 55 
 
Experimental section 
Chemicals and reagents 
cis-UCA and trans-UCA (purity ≥ 98%) were obtained from 
Sigma-Aldrich. Nickel(II) nitrate hexahydrate, 99.999% trace 60 
metal basis, was obtained from Sigma-Aldrich. HEPES was 
obtained from Carl-Roth. Potassium nitrate(V) was purchased 
from Merck. Deionized, ultra-pure Milli-Q water was used for 
sample preparation. In order to prevent UCA isomerisation, all 
experiments were made with special care to protect samples from 65 
ambient light. 
UV-vis titrations 
Two types of UV-vis pH titrations were performed. In the first 
one, samples containing 0.1 mM cis-UCA were titrated with 
NaOH in the pH range of 4.7-9.8. In the second type, samples 70 
containing 4 mM cis-UCA or trans-UCA, 2 mM Ni(NO3)2 and 
100 mM KNO3 were titrated with NaOH in the pH range of 2.6-
8.0. The UV-vis spectra were obtained using a Lambda 950 
UV/Vis/NIR spectrophotometer (Perkin Elmer) at 25 °C over the 
spectral range 200-850 nm. 75 
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Potentiometric titrations 
Potentiometric titration were performed on a 907 Titrando 
automatic titrator (Metrohm), using a Biotrode combined glass 
electrode (Metrohm). The electrode was calibrated daily by nitric 
acid titrations,14 and 100 mM NaOH (carbon dioxide free) was 5 
used as a titrant. Sample volumes of 1.5 mL were used. Samples 
were prepared by dissolving solid cis- or trans-UCA in 4 mM 
HNO3/96 mM KNO3 to obtain a 4 mM UCA concentration. The 
Ni(II) and cis-UCA/trans-UCA complex formation was studied 
using samples in which the molar ratio of cis-UCA/trans-UCA to 10 
Ni(II) were: 2.2:1, 3.3:1, 4.4:1 and 6.7:1. All experiments were 
performed under argon at 25 °C, in the pH range of 2.7-11.0 for 
titration of cis- and trans-UCA, 2.7-8.0 for Ni(II) and cis-UCA, 
and 2.7-6.5 for Ni(II) and trans-UCA. The collected data were 
analysed using the SUPERQUAD and HYPERQUAD 15 
programs.15,16 Five titrations were included simultaneously into 
calculations, separately for protonation and Ni(II) complexation. 
ITC titrations 
ITC experiments were carried out on the Nano ITC Standard 
Volume calorimeter (TA Instrument). The sample cell (950 µL) 20 
was filled with UCA solution and the reference cell was filled 
with the Milli-Q water. The syringe (250 µL) was loaded with a 
Ni(II) solution. The Milli-Q water was degassed under vacuum 
for 15 min before sample preparation. Furthermore, sample 
solutions were degassed for 5 min before loading into the cell and 25 
the syringe. The cell solutions contained 5 mM cis-UCA/trans-
UCA, 100 mM HEPES and 100 mM KNO3 at pH 7.4. The 
syringe solutions contained 25 mM or 50 mM Ni(NO3)2 and 100 
mM KNO3. The pH values of the cell solution did not change 
during titrations. The solutions in the cell were stirred at 170 rpm 30 
by the syringe. Volumes of titrant injections were 2.57 or 4.00 
µL. Intervals between injections were 1000 s to allow complete 
equilibration of the system. The measurements were performed at 
15, 25 or 37 °C for cis-UCA and at 25 °C for trans-UCA. 
Background titrations, consisting of the identical syringe 35 
solutions and the cell solutions except for cis-UCA/trans-UCA 
were subtracted from each experimental titration. The obtained 
data were analyzed with the SEDPHAT program (version 10.58d) 
utilizing the global fitting feature.17 The conditional complex 
formation constants were calculated for the following equilibria: 40 
  KNiL: 𝑁𝑖
2+ + 𝑈𝐶𝐴 ⇄ 𝑁𝑖(𝑈𝐶𝐴) 
  KNiL2: 𝑁𝑖
2+ + 2𝑈𝐶𝐴 ⇄ 𝑁𝑖(𝑈𝐶𝐴)2 
 
Results and discussion 
The pH dependence of UV absorption of cis-UCA is presented in 45 
Fig. 1. The most significant changes, observed at 250 and 290 
nm, allowed us to determine the pKa values for its carboxylate 
and imidazole groups, given in Table 1. The maximum of 
absorption blueshifted from 269 nm to 263 nm for pH 1.7-4.7 and 
back, from 263 nm to 282 nm for pH 4.7-9.8. This shift was not 50 
significantly affected for 0.1 mM cis-UCA by equimolar Ni(II)†. 
However, for higher concentrations (4 mM cis-UCA and 2 mM 
Ni(II)), the pH dependent changes were observed in the regions 
specific for Ni(II) octahedral complexes (~390 nm and ~650 nm) 
(Fig. 2). Such effects were seen neither for cis-UCA nor Ni(II) 55 
alone. For the cis-UCA/Ni(II) system the absorbance maxima 
blue-shifted from 391 nm to 383 nm and from 658 nm to 648 nm. 
The molar absorption for those bands increased along with the 
increasing pH. This effect is typical for substitutions of oxygen 
donors in the first coordination sphere of high-spin Ni(II) 60 
complexes with nitrogens.18 Above pH 8.0 a green precipitate 
appeared in the sample. Dissolution of this precipitate at pH 5 
demonstrated that it was composed predominantly of Ni(OH)2, 
with traces of cis-UCA. Only minor changes in the spectra were 
observed for a sample containing 4 mM trans-UCA and 2 mM 65 
Ni(II), compared to free trans-UCA, and the precipitation 
occurred at pH 6.5. This whitish precipitate was partially re-
dissolved at pH 5. The UV-vis spectra demonstrated that it was 
composed largely of trans-UCA, but also contained significant 
amount of Ni(II). There was no precipitation of trans-UCA seen 70 
in the absence of Ni(II). Therefore, most likely the precipitate 
was composed of Ni(trans-UCA) complex neutralized 
electrostatically by one OH- ion per Ni(II). 
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Fig. 1. The pH dependence of UV spectra of 0.1 mM cis-UCA in pH 
ranges of 1.66-4.73 (A) and 4.73-9.81 (B), and absorbance values of 0.1 85 
mM cis-UCA at 250 and 290 nm (C). 
 
 
 
 90 
 
 
 
 
 95 
Fig. 2. Selected spectra of Ni(II) (2 mM Ni(NO3)2, dashed line) and its 
complexes with cis-UCA (4 mM). The pH values are indicated in the 
graph. 
 Potentiometric titrations of cis-UCA and trans-UCA alone and 
with Ni(II) ions yielded protonation and Ni(II) complexation 100 
constants for both UCA isomers. They are presented in Tables 1 
and 2 in the logarithmic form. Protonation constants for both 
ligands are in a satisfactory accordance with the literature data, 
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obtained solely by UV-vis (lit.,19 3.43 and 5.80 for trans-UCA, 
and 2.7 and 6.65 for cis-UCA). The pKa values determined by 
potentiometry are also close to those obtained in our UV-vis 
titrations. The slight difference (Δ = 0.07) in pKa values for the 
carboxyl group is probably the result of difference in the ionic 5 
strength between these experiments.   
Table 1. Logarithmic protonation constants (log β and pKa) for UCA 
isomers 
Species cis-UCA trans-UCA 
Log β a pKa 
a pKa 
b Log β a pKa 
a 
H2L 9.532(4) 2.79 2.86(4) 9.342(2) 3.51 
HL 6.744(2) 6.74 6.76(4) 5.830(1) 5.83 
 a Values determined by potentiometry at 25 °C and I = 0.1 M 
(KNO3). Standard deviations on the least significant digits, provided by 10 
HYPERQUAD16 are given in parentheses. 
 b Values determined by revealing the pH dependence of 
absorbance at 250 and 290 nm at 25 °C for the experiment shown in Fig. 
1. Standard deviations on the least significant digits are given in 
parentheses. 15 
  
 Both cis-UCA and trans-UCA bind Ni(II) in the 1:1 and 1:2 
metal to UCA ratios. The distributions of species for cis-
UCA/trans-UCA and Ni(II), calculated on the basis of 
potentiometric constants are shown in Fig. 3. It is worth noting 20 
that the complex formation occurs in pH range specific for 
stratum corneum (pH 5-6), with the predominance of 1:1 
complex, and is even more pronounced for deeper layers of the 
skin (pH 6-7.4), with higher amounts of 1:2 complex. 
 On the basis of potentiometric and UV-vis titration data, using 25 
the least square method, the spectra of Ni(cis-UCA) and  
Ni(cis-UCA)2 complexes were calculated and are shown in Fig. 
4. The absorbance maxima for these complexes are 387 (ε/dm3 
mol-1 cm-1 10.5) and 658 nm (2.9), and, 380 (15.3) and 640 nm 
(5.3), respectively. The blueshift of the bands for the latter 30 
complex is in agreement with the stronger ligand field effect 
exerted by the imidazole nitrogen of UCA vs. water molecules.18 
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Fig. 3. Species distributions for Ni(II) complexes in a solution of 2 mM 
Ni(II) and 4 mM cis-UCA (A), 1 µM Ni(II) and 14 mM cis-UCA (B), 2 45 
mM Ni(II) and 4 mM trans-UCA (C) and 1 µM Ni(II) and 6 mM trans-
UCA (D), based on potentiometric data shown in Tables 1 and 2. 
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Fig. 4. Spectra of Ni(cis-UCA) and Ni(cis-UCA)2 complexes, calculated 
on the basis of potentiometric data shown in Tables 1 and 2, and UV-vis 
titration data shown in Fig. 2. 60 
 The analysis of relation between the complex stability and the 
ligand basicity for imidazole-type ligands can help reveal whether 
the chelate effect occurs or the ligand binds the metal ion 
monodentately by its imidazole nitrogen.20,21 Specifically, such 
dependence is linear for ligands with no chelating groups, and for 65 
Ni(II) and the ionic strength of 0.1 M is described by the 
following equation: 
log 𝐾𝑁𝑖𝐿
𝑁𝑖 = 0.225𝑝𝐾𝐻𝐿
𝐻 + 1.380 
 Such relation is shown in Fig. 5 for 1:1 Ni(II) complexes taken 
from the literature,20,22-26 and compared to our data for cis-UCA 
and trans-UCA. The stability constant for trans-UCA is within 70 
the linear correlation observed for ligands interacting only by the 
imidazole part of the molecule (e.g. imidazole, 4-
methylimidazole). It means that only the imidazole nitrogen binds 
Ni(II) in trans-UCA. For cis-UCA the stability enhancement is 
observed, although it is not as large as for e.g. histidine or 75 
histamine. It shows that also the carboxylic moiety participates in 
the interaction of cis-UCA with Ni(II). The carboxylate is not so 
effective in the stabilization of complex as the primary amine in 
histamine or the secondary amine in 4-(2-
methylaminoethyl)imidazole. The Ni(cis-UCA) complex is also 80 
not so stable as complexes with imidazole-4-acetic acid, which 
correlates with the higher stability of 6-membered chelates over 
the 7-membered one which we propose here (Fig 6). 
 The binding of the second molecule of cis-UCA compared to 
the first one is weaker by 0.58 log units (Log βNiL2 – Log βNiL). 85 
The nature of this effect is largely statistical, because this 
difference is only slightly different from the statistical factor of 
0.38, resulting from the decreased number of bidentate binding 
modes for the second ligand molecule (10) vs. the first one (24). 
The bigger difference is probably due to the repulsion between 90 
the carboxyl groups of the two cis-UCA molecules. 
 The analogous statistical factor for the monodentate binding of 
the second trans-UCA molecule is much lower and equal to 0.08 
(Log(6/5)). This explains almost the same binding stability of the 
first and the second trans-UCA molecule. 95 
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Fig. 5. The relation between the Ni(II) complex stability and the ligand 
basicity for imidazole-type ligands, shown for 1:1 Ni(II) complexes taken 
from the literature,21 and compared to our data for cis-UCA and trans-
UCA. The blue line represents linear dependence for ligands binding 20 
Ni(II) monodentately by the imidazole nitrogen (blue circles) described 
by the equation: log𝐾𝑁𝑖𝐿
𝑁𝑖 = 0.225𝑝𝐾𝐻𝐿
𝐻 + 1.380, valid for the 0.1 M ionic 
strength.19,20 Ligands with chelating groups (red squares) show stability 
enhancement. Data shown are for histidine22 (1), 4-(2-
methylaminoethyl)imidazole23 (2), histamine24 (3), 2,2’-biimidazole25 (4), 25 
imidazole-4-acetate25 (5), 4(5)-aminoimidazole-5(4)-carboxamide25 (6), 5-
chloro-1-methylimidazole20 (7), trans-UCA (8), cis-UCA (9), 
imidazole20,24 (10), N-(2,3,5,6-tetrafluorophenyl)imidazole20 (11), 4’-
(imidazol-1-yl)acetophenone20 (12), acetylhistidine26 (13) and 1-
methylimidazole20 (14). 30 
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Fig. 6. The proposed structure of the Ni(cis-UCA) complex. Shown are 
Ni(II), cis-UCA and four water molecules in an octahedral complex. 40 
 ITC experiments were conducted at 15, 25 and 37 °C for cis-
UCA and at 25 °C for trans-UCA, at pH 7.4. The results are 
presented in Tables 2 and 3. Temperature influences only slightly 
the logarithmic stability constants for Ni(cis-UCA) and Ni(cis-
UCA)2 complexes and the binding enthalpy and entropic 45 
contribution  
(-TΔS) for the 1:1 complex. The binding enthalpy for the Ni(cis-
UCA)2 complex is higher at lower temperatures. On the other 
hand, the entropic contribution is higher at higher temperatures 
for the Ni(cis-UCA)2 complex. In the result, the decrease of 50 
enthalpy at higher temperatures is compensated by the increase of 
the entropic contribution, which is reflected in Gibbs energy 
values. The formation of Ni(II) complexes with cis-UCA is 
energetically more favoured compared to trans-UCA in the same 
conditions. 55 
 Ni(II) complex formation constants are higher for cis-UCA 
than for trans-UCA, as revealed by both potentiometry and ITC. 
All values obtained for 25 °C by ITC are lower when compared 
with those obtained by potentiometry at the same temperature. 
The probable reason for this is the different ionic strength used in 60 
ITC (0.15 M) and the presence of HEPES buffer in these 
samples. 
Table 2. Logarithmic Ni(II) complex formation constants for UCA 
isomers 
Species cis-UCA trans-UCA 
15 °C 25 °C 37 °C 25 °C 
Log K a Log K a Log β b Log K a Log K a Log β b 
NiL 3.09(4) 3.09(2) 3.406(4) 3.13(3) 2.53(3) 2.599(7) 
NiL2 5.72(8) 5.61(3) 6.239(4) 5.61(8) 4.04(7) 5.272(7) 
 a Conditional association constant values determined by ITC at 65 
15, 25 and 37 °C, in 0.1 M KNO3, 0.1 M HEPES and pH 7.4. Standard 
deviations on the least significant digits, provided by SEDPHAT17 are 
given in parentheses. 
 b Values determined by potentiometry at 25 °C and I = 0.1 M 
(KNO3). Standard deviations on the least significant digits, provided by 70 
HYPERQUAD16 are given in parentheses. 
 
Table 3. Thermodynamic parameters for Ni(II) complexation determined 
at pH 7.4 by ITC a 
 cis-UCA trans-UCA 
 15 °C 25 °C 37 °C 25 °C 
ΔHNiL -18.6(0.2) -18.2(0.1) -18.4(0.4) -20.0(0.3) 
ΔHNiL2 -26.7(1.6) -22.7(0.7) -18.5(2.4) -20.5(0.1) 
-TΔSNiL 1.5 0.6 -0.2 5.6 
-TΔSNiL2 -4.8 -9.4 -15.7 -2.5 
ΔGNiL -17.1 -17.6 -18.6 -14.4 
ΔGNiL2 -31.5 -32.1 -34.2 -23 
 a The values are presented in kJ mol-1. Standard deviations on 75 
the least significant digits, provided by SEDPHAT17 are given in 
parentheses. 
 
 Of note are higher Gibbs energy values for NiL2 complexes 
compared with NiL, which is in agreement with absorbance 80 
maxima being shifted to shorter wavelengths for Ni(cis-UCA)2 
complex, reflecting the presence of two nitrogen ligands in NiL2 
complexes. 
 We showed that both UCA isomers can bind Ni(II) ions with 
moderate affinity, with a stronger effect visible for cis-UCA. Of 85 
note is a correlation between concentration values in the stratum 
corneum of cis-UCA and Ni(II) ions upon the contact with the 
nickel-releasing material, which are the highest in this part of the 
skin. Considering these facts we propose that urocanic acid, 
especially the cis isomer, can be Ni(II) binding molecule in the 90 
human skin. Based on the literature27,28 we estimated 
concentrations of main components of NMF as 43 mM of serine, 
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30 mM of glycine, 23 mM of pyroglutamic acid, 18 mM of 
alanine, 14 mM of lactic acid, 14 mM of cis-UCA and 6 mM of 
trans-UCA. Concentrations of nickel can be estimated taking as 
the reference the maximum value, allowed by the European 
Union Nickel Directive (Directive 94/27/EC) for the release of 5 
this metal from products intended to come into direct, prolonged 
contact with skin, being equal to 0.5 µg cm-2 per week.11 Locally 
this concentration can probably easily reach a micromolar level in 
the stratum corneum, especially because some kinds of jewelry 
and coins release 100 times more nickel than allowed by the 10 
Directive.29,30 Taking the protonation constants and stability 
constants of Ni(II) complexes from the literature26,31,32 and from 
this paper we calculated the distribution of Ni(II) species for 
above concentrations of ligands and of 1 µM nickel ions (Fig. 7). 
At pH 5.6 22% of Ni(II) is complexed with cis-UCA, which 15 
places this molecule as the second binding compound, after 
serine. 10% of Ni(II) is in complex with trans-UCA. At pH 6.5, 
still 22% of Ni(II) is bound with cis-UCA, after serine. The 
formation of Ni(II)-UCA complexes can be even more 
pronounced following the intended use of cis-UCA as a 20 
component of pharmaceuticals. Topical application of cis-UCA 
has been proposed as a safe and effective way to treat 
inflammatory skin disorders.8,9 Deeper investigation is needed as 
it was shown that cis-UCA can form a complex with human 
serum albumin (HSA),33 another Ni(II)-binding biomolecule.34 25 
The general important issue which remains to be resolved is 
whether cis-UCA plays a role of a transporting or rather a 
buffering agent for Ni(II) ions in the human organism. 
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Fig. 7. Ni(II) species distribution simulated for NMF and 1 µM Ni2+ ions. 
The protonation constants and stability constants of Ni(II) complexes 
were taken from the literature26,31,32 and from this paper. Concentrations 40 
taken for calculations are 43 mM serine, 30 mM glycine, 23 mM 
pyroglutamic acid (PCA), 18 mM alanine, 14 mM lactic acid (Lac), 14 
mM cis-UCA and 6 mM trans-UCA.27,28 The binding of Ni(II) by alanine 
in this conditions is negligible and omitted for clarity. 
 45 
Conclusions 
We proved that cis-UCA molecule interacts with Ni(II) ions with 
moderate stability, the complexes being strong enough to exist in 
physiological conditions in the outermost layers of the human 
skin, with consequences for nickel toxicity. 50 
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